Concepedia
Statistics
Publications
8
Citations
113
H-Index
Active since
1982
Affiliations
Heidelberg University(Current)
German Cancer Research Center
D. Todorov is an author at Heidelberg University specializing in cancer pharmacology, pharmacology, and oncology.
Publications per year
1982–2003
Membrane effects of the antitumor drugs doxorubicin and thaliblastine: comparison to multidrug resistance modulators verapamil and trans-flupentixol
Ilza Pajeva, D. Todorov, Joachim K. Seydel · European Journal of Pharmaceutical Sciences · 2003 · 22 citations
Medicine, Oncology, Pharmacology +10
Does Verapamil Help Overcome Multidrug Resistance in Tumor Cell Lines and Cancer Patients?
Constanta Timcheva, D. Todorov · Journal of Chemotherapy · 1996 · 18 citations
Medicine, Oncology, Pharmacology +15
Antiproliferative activity of the non-myelotoxic antitumour agent of plant origin, Thaliblastine, on two human glioma cell lines
D. Todorov, W. Jens Zeller · Journal of Cancer Research and Clinical Oncology · 1992 · 15 citations · Full text
Incorporation of the antitumor alkaloid thaliblastine in liposomes enhances its cytotoxic activity in vitro
D. Todorov, George Deliconstantinos · Cellular and Molecular Life Sciences · 1982 · 15 citations
Medicine, Oncology, Pharmacology +8
Dominant-lethal mutations and micronucleus induction in male BALB/c, BDF1 and H mice by tobacco smoke
I. Stoichev, D. Todorov, Lora T. Christova · Mutation Research/Genetic Toxicology · 1993 · 12 citations
Pharmacy, Biology, Toxicology +14
1–5 of 8